Returning for a second year the Synthetic Biology-Based Therapies Summit is the leading industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization. Download the event guide to find out more Learn from industry trailblazers at Arsenal Biosciences, bit.bio, Moderna, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your […]

The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products. How will you comply with the EU MDR? What is the best strategy to ensure widespread clinical adoption and reimbursement? What can you do to engage with other wound care companies, for collaboration or acquisition? Expect to hear […]

PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups! The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification. The attendees at PURIFY get exposed to a myriad of topics […]

SAE Media Group’s 15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe January 10 - 12 2023 | London, UK http://www.pre-filled-syringes.com/pharmajournalist ------------------------------------------------------------------------- The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. […]

11th Annual Pharmaceutical Microbiology Conference  16 - 17 January 2023 London, UK http://www.pharma-microbiology.com/PJwl  Sponsored by: Microgenetics  Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi  Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy  We are delighted to announce SAE’s 11th Annual Pharmaceutical Microbiology Europe Conference taking place in […]

The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your […]

SAE Media Group’s 2nd Annual Conference Transdermal and Microneedle Drug Delivery January 23 - 24, 2023 | London, UK www.transdermal-microneedle-delivery.co.uk/pharmajournalistel ------------------------------------------------------------------------- SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023. The 2023 Transdermal and Microneedle Drug Delivery Conference will […]

The 2nd Annual mRNA-Based Therapeutics Summit Europe is the only end-to-end mRNA-dedicated meeting in Europe and the largest gathering for mRNA professionals outside of the United States. Built with biopharmaceutical industry insights, this meeting will unite KOLs from Europe and the rest of the world to delve into the challenges associated with successfully designing and […]

The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023. The DNA damage response inhibitor space only continues to grow, with progress being accelerated by a shift in focus onto next-generation targets like PolQ and WRN, moving forward from monotherapies through combining targets […]

The 2nd HFpEF & HCM Drug Discovery & Development Summit is the definitive industry forum dedicated to propelling drug discovery and development across emerging therapeutics including cell and gene therapies and the implementation of precision medicine. Shake hands with industry pioneers prioritizing the development of therapeutic treatments to complement the new standard of care with […]

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology. In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge […]

Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where […]

SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK. Building on the success of previous years, the RNA Therapeutics Conference will bring together industry experts from leading pharma and biotech companies to provide an expert and holistic view on the […]

Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations. At a time when both payers and providers are evaluating and streamlining internal payment and revenue integrity processes, this networking conference has been established to breakdown silos, […]

6th Annual 3D Cell Culture Conference 8-9 February 2022 London, UK http://www.3D-cellculture.com/PJwl Sponsored: CelVivo, Promega and Systemic Bio Conference Co-chairs: Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck Rhiannon David, Director, Microphysiological Systems, AstraZeneca  Exploring the implementation of complex in-vitro models for drug development Join us in February 2023, as SAE Media Group’s 6th annual […]

The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate share the challenges and opportunities of translating cutting-edge CRISPR technology into a tangible product. If you are working to advance genome-edited crops or plants, this […]

Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases. The management of these diseases has made remarkable advancements in previous years, but the burden on patients remains high, posing a need to develop novel therapeutics and […]

 Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster. Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking […]

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit […]

Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map. Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s […]

Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to existing programs and safety bottlenecks threaten further progress. The next wave of kinase targets depends on innovation. Join the 2nd Next Generation Kinase Inhibitors Summit to connect […]

Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells Selective cell entry, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action […]

SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 – 14 March 2023 in London, UK. With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through […]

As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing […]

Patient-first. Collaborative. Data and insights driven. Digitally underpinned. These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust. To capitalize on three years of extraordinary momentum and lead healthcare’s reform, pharma must embody […]

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. Your industry-defining Innate Killer Summit brings crucial insights for everyone on your team, with 4 content tracks spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing, this is the definitive meeting to […]

The first TCR-based therapy approval in the US and Europe at the start of last year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it’s time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to […]

Hijacking E3 Ligases to Mediate Degradation & Modulation of Undrugged Targets As a family of over 600 known proteins, ligases pose immense potential as viable avenues for harnessing previously undrugged targets. Key challenges remain however to rapidly discover and identify novel and underexploited ubiquitin E3s. Furthermore, bottlenecks exist in the development of the established ligases; […]

Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, the 2nd LNP Formulation & Process Development Summit is your must-attend meeting as this nanoparticle continues to dominate the biopharmaceutical industry in 2023. New for […]

The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune diseases as the next big drug opportunity. The 3rd Fc Receptor Pathway Targeted Therapies Summit will once again feature unmissable conversations to advance targeting FcR […]